Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

The Medtronic Heartware and Abbott Heartmate 3 LVADs and others currently cleared by the FDA might be easier to use in Medicare advanced heart failure patients under new guidelines proposed by CMS. Photo by Dave Fornell
Feature | Heart Failure | Dave Fornell, Editor

August 21, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) proposed updates to coverage policies for to ...

Home August 21, 2020
Home
News | Heart Failure

 


August 17, 2020 — Pupil size predicts death and hospital readmission in patients with heart failure, according to r ...

Home August 17, 2020
Home
News | Remote Monitoring

August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a multi ...

Home August 05, 2020
Home
News | Heart Failure

August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in ...

Home August 04, 2020
Home
Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 
Feature | Dave Fornell, Editor

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) mag ...

Home August 03, 2020
Home
News | Pharmaceuticals

July 28, 2020 — AstraZeneca's heart failure medication dapagliflozin (Farxiga) significantly reduced the worsening of ...

Home July 28, 2020
Home
News | Heart Failure

July 9, 2020 – The Minneapolis Heart Institute Foundation (MHIF) is conducting additional research on a novel hydrogel ...

Home July 09, 2020
Home
News | Heart Failure

June 30, 2020 —  BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The ...

Home June 30, 2020
Home
News | Heart Failure

June 23, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Program status for the ...

Home June 23, 2020
Home
Russian interventional cardiologist Alexey Pankov in full personal protective equipment (PPE) for a cath lab procedure in Moscow during the COVID-19 era. Right, an image of the COVID-19 virus from the National Institutes of Health (NIH).
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

It was originally thought novel coronavirus (COVID-19, SARS-CoV-2) was primarily a respiratory disorder, but as larger ...

Home June 05, 2020
Home
News | Ventricular Assist Devices (VAD)

May 29, 2020 — Medtronic is recalling its HeartWare HVAD left ventricular assist device (LVAD) pump outflow graft and ...

Home May 29, 2020
Home
News | Artificial Heart

May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first ...

Home May 27, 2020
Home
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.20 annual meeting March 28-30, 2020, in Chicago. This includes five late-breaking clinical trial (LBCT) sessions and three featured clinical research sessions. There also are two LBCT deep-dive sessions where the experts will break down the hottest trials and attendees can find out what the impact might be on the practice of cardiology and patients.
Feature | ACC | Dave Fornell, Editor

Here is the list of American College of Cardiology (ACC) practice-changing late-breaking study presentations at the ACC ...

Home April 09, 2020
Home
News | Heart Failure

March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the investigational ...

Home March 29, 2020
Home
News | Heart Failure

March 28, 2020 — New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse ...

Home March 28, 2020
Home
Subscribe Now